Evaluation of the Diagnostic Value of the Ultrasound ADNEX Model for Benign and Malignant Ovarian Tumors

References

• Giampaolino P, Della Corte L, Foreste V, et al. Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer. Minerva Med. 2019;110(4):279–291. doi:10.23736/S0026-4806.19.06086-5
   PubMed Web of Science ®Google Scholar
• Guo W, Zou X, Xu H, et al. The diagnostic performance of the Gynecologic Imaging Reporting and Data System (GI-RADS) in adnexal masses. Ann Transl Med. 2021;9(5):398. doi:10.21037/atm-20-5170
   PubMed Web of Science ®Google Scholar
• Froyman W, Wynants L, Landolfo C, et al. Validation of the performance of International Ovarian Tumor Analysis (IOTA) methods in the diagnosis of early stage ovarian cancer in a non-screening population. Diagnostics (Basel). 2017;7(2):32.
   PubMedGoogle Scholar
• Froyman W, Timmerman D. Methods of assessing ovarian masses: international ovarian tumor analysis approach. Obstet Gynecol Clin North Am. 2019;46(4):625–641. doi:10.1016/j.ogc.2019.07.003
   PubMed Web of Science ®Google Scholar
• Sayasneh A, Ferrara L, De Cock B, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study. Br J Cancer. 2016;115(5):542–548. doi:10.1038/bjc.2016.227
   PubMed Web of Science ®Google Scholar
• Van Calster B, Van Hoorde K, Valentin L, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014;349:g5920. doi:10.1136/bmj.g5920
   PubMed Web of Science ®Google Scholar
• Van Calster B, Van Hoorde K, Froyman W, et al. Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors. Facts Views Vis Obgyn. 2015;7(1):32–41.
   PubMedGoogle Scholar
• Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol. 2000;16(5):500–505. doi:10.1046/j.1469-0705.2000.00287.x
   PubMed Web of Science ®Google Scholar
• Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1–5. doi:10.1016/j.ijgo.2013.10.001
   PubMed Web of Science ®Google Scholar
• Meinhold-Heerlein I, Fotopoulou C, Harter P, et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet. 2016;293(4):695–700. doi:10.1007/s00404-016-4035-8
   PubMed Web of Science ®Google Scholar
• Phinyo P, Patumanond J, Saenrungmuaeng P, et al. Diagnostic added-value of serum CA-125 on the IOTA simple rules and derivation of practical combined prediction models (IOTA SR X CA-125). Diagnostics (Basel). 2021;11(2):173.
   PubMedGoogle Scholar
• Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee. Radiology. 2020;294(1):168–185. doi:10.1148/radiol.2019191150
   PubMed Web of Science ®Google Scholar
• Gaurilcikas A, Gedgaudaite M, Cizauskas A, et al. Performance of the IOTA ADNEX model on selected group of patients with borderline ovarian tumours. Medicina (Kaunas). 2020;56(12):690.
   PubMed Web of Science ®Google Scholar
• Nohuz E, De Simone L, Chêne G. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women. J Gynecol Obstet Hum Reprod. 2019;48(2):103–107. doi:10.1016/j.jogoh.2018.04.012
   PubMed Web of Science ®Google Scholar
• Jeong SY, Park BK, Lee YY, Kim TJ. Validation of IOTA-ADNEX model in discriminating characteristics of adnexal masses: a comparison with subjective assessment. J Clin Med. 2020;9(6):2010. doi:10.3390/jcm9062010
   PubMed Web of Science ®Google Scholar
• Pereira PN, Sarian LO, Yoshida A, et al. Improving the performance of IOTA simple rules: sonographic assessment of adnexal masses with resource-effective use of a magnetic resonance scoring (ADNEX MR scoring system). Abdom Radiol (NY). 2020;45(10):3218–3229. doi:10.1007/s00261-019-02207-9
   PubMed Web of Science ®Google Scholar
• Chen H, Qian L, Jiang M, Du Q, Yuan F, Feng W. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China. Ultrasound Obstet Gynecol. 2019;54(6):815–822. doi:10.1002/uog.20363
   PubMed Web of Science ®Google Scholar
• Araujo KG, Jales RM, Pereira PN, et al. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound Obstet Gynecol. 2017;49(6):778–783. doi:10.1002/uog.15963
   PubMed Web of Science ®Google Scholar
• Epstein E, Van Calster B, Timmerman D, Nikman S. Subjective ultrasound assessment, the ADNEX model and ultrasound-guided tru-cut biopsy to differentiate disseminated primary ovarian cancer from metastatic non-ovarian cancer. Ultrasound Obstet Gynecol. 2016;47(1):110–116. doi:10.1002/uog.14892
   PubMed Web of Science ®Google Scholar
• Szubert S, Wojtowicz A, Moszynski R, et al. External validation of the IOTA ADNEX model performed by two independent gynecologic centers. Gynecol Oncol. 2016;142(3):490–495. doi:10.1016/j.ygyno.2016.06.020
   PubMed Web of Science ®Google Scholar
• Tug N, Yassa M, Akif Sargın M, Dogan Taymur B, Sandal K, Mega E. Preoperative discriminating performance of the IOTA-ADNEX model and comparison with Risk of Malignancy Index: an external validation in a non-gynecologic oncology tertiary center. Eur J Gynaecol Oncol. 2020;41(2):200–207.
   Web of Science ®Google Scholar
• Joyeux E, Miras T, Masquin I, Duglet PE, Astruc K, Douvier S. Prédictibilité préopératoire de la malignité des tumeurs ovariennes à partir du score ADNEX et utilisation en pratique clinique. Gynecol Obstet Fertil. [Before surgery predictability of malignant ovarian tumors based on ADNEX model and its use in clinical practice]. 2016;44(10):557–564. French. doi:10.1016/j.gyobfe.2016.07.007
   PubMedGoogle Scholar
• Greenhalgh T, Howick J, Maskrey N; Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725. doi:10.1136/bmj.g3725
   PubMed Web of Science ®Google Scholar
• Wynants L, Timmerman D, Verbakel JY, et al. Clinical utility of risk models to refer patients with adnexal masses to specialized oncology care: multicenter external validation using decision curve analysis. Clin Cancer Res. 2017;23(17):5082–5090. doi:10.1158/1078-0432.CCR-16-3248
   PubMed Web of Science ®Google Scholar
• Meys EMJ, Jeelof LS, Achten NMJ, et al. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods. Ultrasound Obstet Gynecol. 2017;49(6):784–792. doi:10.1002/uog.17225
   PubMed Web of Science ®Google Scholar